Stratasys Opens Enrollment for 3DHEART Clinical Study on Effects of 3D Printed Heart Models in Surgery 3D Printing Processes
Stratasys, the 3D printing and additive manufacturing solutions market leader, today announced enrollment is now open for 3DHEART, an investigator initiated trial. 3DHEART, which stands for 3D Hearts Enabling A Randomized Trial, is a randomized, single-blind clinical trial to study the use of patient-specific 3D printed models in pre-operative planning for pediatric heart surgery. Stratasys is providing in-kind support with printing of the models to be used in the trial.